Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:TRIM28 selective nanobody reduces glioblastoma stem cell invasion
Authors:ID Porčnik, Andrej (Author)
ID Novak, Metka (Author)
ID Breznik, Barbara (Author)
ID Majc, Bernarda (Author)
ID Hrastar, Barbara (Author)
ID Šamec, Neja (Author)
ID Zottel, Alja (Author)
ID Jovchevska, Ivana (Author)
ID Vittori, Miloš (Author)
ID Rotter, Ana (Author)
ID Komel, Radovan (Author)
ID Lah Turnšek, Tamara (Author)
Files:URL URL - Source URL, visit https://www.mdpi.com/1420-3049/26/17/5141
 
.pdf PDF - Presentation file, download (1,60 MB)
MD5: 8E2816BA56D977D7F1A4215CE159DCD6
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo NIB - National Institute of Biology
Abstract:Glioblastoma (GB), is the most common and aggressive malignant primary brain tumour in adults. Intra- and inter-tumour heterogeneity, infiltrative GB cell invasion and presence of therapy-resistant GB stem cells (GSCs) represent major obstacles to favourable prognosis and poor therapy response. Identifying the biomarkers of the most aggressive tumour cells and their more efficient targeting strategies are; therefore, crucial. Recently, transcription factor TRIM28 has been identified as a GB biomarker and, in this study, we have shown high expression of TRIM28 in GB and in low grade gliomas as well as higher expression in GSCs vs. differentiated GB cells, although in both cases not significant. We demonstrated significant in vitro inhibition of GB cells and GSCs invasiveness and spread in zebrafish brains in vivo by anti-TRIM28 selective nanobody NB237. TRIM28 was also enriched in GB (tumour) core and associated with the expression of stem cell genes, but was not prognostic for overall survival. However, based on the above results, we conclude that TRIM28 nanobody NB237 offers a new opportunity as a GB therapeutic tool.
Publication status:Published
Publication version:Version of Record
Publication date:25.08.2021
Year of publishing:2021
Number of pages:str. 1-16
Numbering:Vol. 26, iss. 17
PID:20.500.12556/DiRROS-19497 New window
UDC:620.3:620.1/.2
ISSN on article:1420-3049
DOI:10.3390/molecules26175141 New window
COBISS.SI-ID:74227715 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 26. 8. 2021; Metka Novak, Barbara Breznik, Bernarda Majc, Barbara Hrastar, Neja Šamec, Alja Zottel, Ivana Jovčevska, Miloš Vittori, Ana Rotter, Radovan Komel, Tamara Lah Turnšek; Št. članka 26175141;
Publication date in DiRROS:19.07.2024
Views:259
Downloads:208
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Molecules
Shortened title:Molecules
Publisher:MDPI
ISSN:1420-3049
COBISS.SI-ID:18462981 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0245-2019
Name:Ekotoksiologija, toksikološka genomika in karcinogeneza

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z3-1870-2019
Name:Vpliv mezenhimskih matičnih celic na odpornost glioblastoma na terapijo

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z3-1869-2019
Name:Razvoj anti-FREM2 nanotelesa in njegova uporaba pri ciljanju glioblastomskih celic.

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z3-2649-2020
Name:Določitev novih biomarkerjev glioblastoma za namen neinvazivne tekočinske biopsije

Funder:EC - European Commission
Funding programme:European Program of Cross-Border Cooperation for Slovenia-Italy Interreg
Acronym:TRANS-GLIOMA

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:glioblastom, TRIM28, nanoprotitelesa


Back